Literature DB >> 26067487

Strategies for implementation of an effective pharmacogenomics program in pharmacy education.

U Subrahmanyeswara Rao1, Susan L Mayhew2, Prema S Rao1.   

Abstract

Sequencing of the human genome and the evidence correlating specific genetic variations to diseases have opened up the potential of genomics to more effective and less harmful interventions of human diseases. A wealth of pharmacogenomics knowledge is in place for the practice of precision medicine. However, this knowledge is not fully realized in clinical practice. One reason for this impasse is the lack of in-depth understanding of the potential of pharmacogenomics among the healthcare professionals. Pharmacists are the point-of-care providers and are expected to advise clinicians on matters relating to the implementation of pharmacogenomics in patient care. However, current pharmacogenomics instruction in pharmacy schools fails to produce pharmacists with the required knowledge or practical training in this discipline. In this perspective, we provide several strategies to overcome limitations faced by pharmacy schools. Once implemented, pharmacy schools will produce precision medicine-ready pharmacists.

Entities:  

Keywords:  PharmD curriculum; didactic instruction; education instruction; genetics; pharmacogenomics; pharmacy education; precision medicine; strategies for implementation

Mesh:

Year:  2015        PMID: 26067487     DOI: 10.2217/pgs.15.50

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  9 in total

1.  Pharmacogenomics Education Improves Pharmacy Student Perceptions of Their Abilities and Roles in Its Use.

Authors:  Rebecca Marcinak; Meaghan Paris; Shannon R M Kinney
Journal:  Am J Pharm Educ       Date:  2018-11       Impact factor: 2.047

2.  Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.

Authors:  Susanne B Haga; Jivan Moaddeb; Rachel Mills; Deepak Voora
Journal:  Pharmacogenomics       Date:  2017-02-22       Impact factor: 2.533

Review 3.  Educational strategies to enable expansion of pharmacogenomics-based care.

Authors:  Kristin Wiisanen Weitzel; Christina L Aquilante; Samuel Johnson; David F Kisor; Philip E Empey
Journal:  Am J Health Syst Pharm       Date:  2016-12-01       Impact factor: 2.637

4.  Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients.

Authors:  Amber E Johnson; Gretchen M Swabe; Daniel Addison; Utibe R Essien; Khadijah Breathett; LaPrincess C Brewer; Sula Mazimba; Selma F Mohammed; Jared W Magnani
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-05-13

5.  Participatory Genomic Testing Can Effectively Disseminate Cardiovascular Pharmacogenomics Concepts within Federally Qualified Health Centers: A Feasibility Study.

Authors:  Amber Johnson; Stephen Broughton; Lisa Aponte-Soto; Karriem Watson; Carla Da Goia Pinto; Philip Empey; Steven Reis; Robert Winn; Mylynda Massart
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

6.  Integrating pharmacogenetic testing into primary care.

Authors:  Susanne B Haga
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-11-03

7.  Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists.

Authors:  Amber Frick; Cristina S Benton; Kelly L Scolaro; Jacqueline E McLaughlin; Courtney L Bradley; Oscar T Suzuki; Nan Wang; Tim Wiltshire
Journal:  Front Pharmacol       Date:  2016-08-08       Impact factor: 5.810

8.  Pharmacogenomics: From classroom to practice.

Authors:  Samantha C Nutter; Marina Gálvez-Peralta
Journal:  Mol Genet Genomic Med       Date:  2018-05-31       Impact factor: 2.183

Review 9.  Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges.

Authors:  Catriona Hippman; Corey Nislow
Journal:  J Pers Med       Date:  2019-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.